USPTO serial 79132964
VERVANIS
Reviewed by CopyMark Law Group
Reg. 4565946Status 404
- Filing date
- Status date
- Registration date
- Jul 15, 2014
- Examiner
- SPILS, CAROL A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VERVANIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the manufacture of injectable foams | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; sterilizing preparations | SECTION 71 - CANCELLED | — |
| 010 | Needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions | SECTION 71 - CANCELLED | — |
| 042 | Scientific research services related to sclerotherapy of veins including research relating to provision of treatment in the fields of phlebology, proctology and angiology | SECTION 71 - CANCELLED | — |
| 044 | Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical evaluation of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical treatment of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical services provided to post-treatment and homecare patients in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; providing outpatient medical services regarding the administering of medications and therapy in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Provensis Limited
- Other trademarks owned by Provensis Limited
- Other trademarks owned by Provensis Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VERVANIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Apr 23, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 20, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 19, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 19, 2022 | INPC | INVALIDATION PROCESSED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 30, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 15, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 15, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 15, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 15, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 25, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 9, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 9, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 9, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 26, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 26, 2014 | ALIE | ASSIGNED TO LIE | — |
| Mar 11, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2013 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 12, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 12, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 26, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 25, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |